Paper - WANFANG MED ONLINE

You Position: Home > Paper

Research progress of mast cell activation-related receptors and their functions

( views:12, downloads:0 )

Author:: No author available

Journal Title:: Acta Physiologica Sinica

Issue:: 4

DOI:: 10.13294/j.aps.2019.0042

Key Word:: 肥大细胞;受体;功能;信号通路

Abstract：肥大细胞广泛分布于机体各个部位,常见于机体与外部环境之间的粘膜表面,是重要的免疫细胞之一,在固有免疫、适应性免疫及免疫调节中发挥着重要的作用.研究表明,肥大细胞的过度激活与哮喘、过敏性鼻炎、食物过敏、急慢性瘙痒等过敏性及炎性疾病的发生、发展密切相关,主要表现为肥大细胞向炎症部位浸润并释放多种过敏介质.阻断肥大细胞激活可作为有效治疗过敏性及炎性疾病的手段之一,因此与肥大细胞激活相关的受体是临床药物开发的有效靶点.激活肥大细胞的相关受体种类较多,并且不同的受体所介导产生的效应也不尽相同,新的肥大细胞受体不断被发现,然而,对这些研究的梳理比较少.本综述总结了参与肥大细胞激活的相关受体,依据不同效应对受体进行分类,并对其下游信号通路及应用进行阐述.

Reference

[1]Jensen BM,Metcalfe DD,Gilfillan AM.Targeting kit activation: a potential therapeutic approach in the treatment of allergic inflammation.[J].2007,6(1).
[2]Ana M Avalos,Hidde L Ploegh,Clarissa C Lee.Accessory molecules for Toll-like receptors and their function.[J].2012,12(3).
[3]Sugimori, Yayoi,Ota, Tsuyoshi,Ujihira, Takafumi,etc.A phase II randomised study to evaluate the efficacy of aprepitant plus palonosetron for preventing delayed-phase CINV associated with TC therapy in gynaecological cancer.[J].2017,43(9).
[4]Joakim S. Dahlin,Jenny Hallgren.Mast cell progenitors: Origin, development and migration to tissues[J].2015,63(1).
[5]Michael, Stassen,Lothar, Hültner,Edgar, Schmitt.Classical and alternative pathways of mast cell activation.[J].2002,22.
[6].Differential RNA splicing predicts two distinct nerve growth factor precursors[J].1986,319(6056).
[7]Mrabet-Dahbi S,Maurer M,Dudeck A,etc.Murine mast cells secrete a unique profile of cytokines and prostaglandins in response to distinct TLR2 ligands.[J].2009,18(5).
[8]Subramanian, Hariharan,Gupta, Kshitij,Ali, Hydar.Roles of Mas-related G protein-coupled receptor X2 on mast cell-mediated host defense, pseudoallergic drug reactions, and chronic inflammatory diseases[J].2016,138(3).
[9]M Caleb, Marlin,Guangpu, Li.Biogenesis and function of the NGF/TrkA signaling endosome.[J].2015,314.
[10]Tebas, Pablo,Spitsin, Sergei,Barrett, Jeffrey S.,etc.Reduction of soluble CD163, substance P, programmed death 1 and inflammatory markers: phase 1B trial of aprepitant in HIV-1-infected adults[J].2015,29(8).
[11]Emmanuel Donnadieu,Marie-Hélène Jouvin,Jean-Pierre Kinet.A Second Amplifier Function for the Allergy-Associated FcεRI-β Subunit[J].2000,12(5).
[12]Mattias, Enoksson,Karin F K, Ejendal,Sarah, McAlpine,etc.Human cord blood-derived mast cells are activated by the Nod1 agonist M-TriDAP to release pro-inflammatory cytokines and chemokines.[J].2011,3.
[13]Kedzierski RM,Yanagisawa M.Endothelin system: the double-edged sword in health and disease.[J].2001,41.
[14]Sonia Varadaradjalou,Frédéric Féger,Nathalie Thieblemont,etc.Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells[J].2003,33(4).
[15]Ferjan I,Stempelj M.Signaling pathway in nerve growth factor induced histamine release from rat mast cells.[J].2005,54(8).
[16]Menzfeld, Christiane,John, Michael,van Rossum, Denise,etc.Tyrphostin AG126 Exerts Neuroprotection in CNS Inflammation by a Dual Mechanism[J].2015,63(6).
[17].Expression of surface and intracellular Toll-like receptors by mature mast cells[J].2017,4.
[18]Buerke M,Schmitt E,Finotto S,etc.Local administration of antisense phosphorothioate oligonucleotides to the c-kit ligand, stem cell factor, suppresses airway inflammation and IL-4 production in a murine model of asthma.[J].2001,107(2).
[19]McNeil, Benjamin D.,Pundir, Priyanka,Meeker, Sonya,etc.Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions[J].2015,519(Mar.12 TN.7542).
[20]N Q, McDonald,R, Lapatto,J, Murray-Rust,etc.New protein fold revealed by a 2.3-A resolution crystal structure of nerve growth factor.[J].1991,354(6352).
[21]S, Koizumi,M L, Contreras,Y, Matsuda,etc.K-252a: a specific inhibitor of the action of nerve growth factor on PC 12 cells.[J].1988,8.
[22]U, Blank,C, Ra,L, Miller,etc.Complete structure and expression in transfected cells of high affinity IgE receptor.[J].1989,337.
[23]Steven D. Douglas,Susan E. Leeman.Neurokinin-1 receptor: functional significance in the immune system in reference to selected infections and inflammation[J].2011,1217.
[24]Toshiaki, Kawakami,Jiro, Kitaura,Wenbin, Xiao,etc.IgE regulation of mast cell survival and function.[J].2005,271.
[25]Moriconi, Alessio,Cunha, Thiago M.,Souza, Guilherme R.,etc.Targeting the minor pocket of C5aR for the rational design of an oral allosteric inhibitor for inflammatory and neuropathic pain relief[J].2014,111(47).
[26]Gege, Li,Jiahui, Pan,Qiuling, Tang,etc.Anti-inflammatory Effects of PMX205 in Mouse Macrophage Periodontitis Model.[J].2018,15(2).
[27]S G, el-Lati,C A, Dahinden,M K, Church.Complement peptides C3a- and C5a-induced mediator release from dissociated human skin mast cells.[J].1994,102.
[28]Abraham SN,St John AL.Mast cell-orchestrated immunity to pathogens.[J].2010,10(6).
[29]Hideki Yamamura,Takeshi Nabe,Shigekatsu Kohno,etc.Endothelin-1 induces release of histamine and leukotriene C4 from mouse bone marrow-derived mast cells[J].1994,257(3).
[30]Cardamone, Chiara,Parente, Roberta,De Feo, Giulia,etc.Mast cells as effector cells of innate immunity and regulators of adaptive immunity[J].2016,178.
[31]Marianna Kulka,Cecilia H. Sheen,Brian P. Tancowny,etc.Neuropeptides activate human mast cell degranulation and chemokine production[J].2008,123(3).
[32]Spitsin Sergei,Pappa Vasiliki,Douglas Steven D..Truncation of neurokinin‐1 receptor—Negative regulation of substance P signaling[J].2018,103(6).
[33]Kimura,Y.,Chihara,K.,Honjoh,C.,etc.Dectin-1-mediated signaling leads to characteristic gene expressions and cytokine secretion via spleen tyrosine kinase (Syk) in rat mast cells[J].2014,289(45).
[34]Hirohisa Saito.Mast Cell Research[J].2014,100.
[35]Rui Liu,Delu Che,Tingting Zhao,etc.MRGPRX2 is essential for sinomenine hydrochloride induced anaphylactoid reactions[J].2017,146.
[36]Marshall JS,Blennerhassett MG,Gomi K,etc.Nerve growth factor modifies the expression of inflammatory cytokines by mast cells via a prostanoid-dependent mechanism.[J].1999,162(7).
[37]Malbec O,Roget K,Schiffer C,etc.Peritoneal cell-derived mast cells: an in vitro model of mature serosal-type mouse mast cells.[J].2007,178(10).
[38]Moses V. Chao.Neurotrophins and Their Receptors: A Convergence Point for Many Signalling Pathways[J].2003,4(4).
[39]Frossard N,Reber L,Da Silva CA.Stem cell factor and its receptor c-Kit as targets for inflammatory diseases.[J].2006,533(1).
[40]Cho S.-H.,You H.-J.,Woo C.-H.,etc.Rac and Protein Kinase C-\u00a0 Regulate ERKs and Cytosolic Phospholipase A2 in Fc\u00a0RI Signaling to Cysteinyl Leukotriene Synthesis in Mast Cells[J].2004.
[41]Nakano Y,Kawamoto A,Chida K,etc.Elevated complement C3a in plasma from patients with severe acute asthma.[J].2003,112(3).
[42]Acin, Francisco,Bleda, Silvia,Varela, Cesar,etc.Effect of Bosentan on Claudication Distance and Endothelium-Dependent Vasodilation in Hispanic Patients With Peripheral Arterial Disease[J].2016,117(2).
[43]E, Eiseman,J B, Bolen.Engagement of the high-affinity IgE receptor activates src protein-related tyrosine kinases.[J].1992,355(6355).
[44]Kinet,JP.The high-affinity IgE receptor (Fc epsilon RI): from physiology to pathology.[J].1999,17.
[45]Hilary, Sandig,Silvia, Bulfone-Paus.TLR signaling in mast cells: common and unique features.[J].2012,3.
[46]Gonzalez-Espinosa, Claudia .,Avila, Martin.Signaling Through Toll-like Receptor 4 and Mast Cell-dependent Innate Immunity Responses[J].2011,63(10).
[47]Sergio, Berdún,Jakub, Rychter,Patri, Vergara.Effects of nerve growth factor antagonist K252a on peritoneal mast cell degranulation: implications for rat postoperative ileus.[J].2015,309(10).
[48]Ratti,E.,Bettica,P.,Alexander,R.,etc.Full central neurokinin-1 receptor blockade is required for efficacy in depression: Evidence from orvepitant clinical studies[J].2013,27(5).
[49]T M, Fong,S A, Anderson,H, Yu,etc.Differential activation of intracellular effector by two isoforms of human neurokinin-1 receptor.[J].1992,41.
[50]Trower, Michael K.,Fisher, Amy,Upton, Neil,etc.Neurokinin-1 receptor antagonist orvepitant is an effective inhibitor of itch-associated response in a Mongolian gerbil model of scratching behaviour[J].2014,23(11).
[51]Thomas R, Hundley,Alasdair M, Gilfillan,Christine, Tkaczyk,etc.Kit and FcepsilonRI mediate unique and convergent signals for release of inflammatory mediators from human mast cells.[J].2004,104.
[52]Sch?fer,B.,Piliponsky,A.M.,Oka,T.,etc.Mast cell anaphylatoxin receptor expression can enhance IgE-dependent skin inflammation in mice[J].2013,131(2).
[53]G F, Joos,W, Vincken,R, Louis,etc.Dual tachykinin NK1/NK2 antagonist DNK333 inhibits neurokinin A-induced bronchoconstriction in asthma patients.[J].2004,23.
[54]Ali H.Regulation of human mast cell and basophil function by anaphylatoxins C3a and C5a.[J].2010,128(1).
[55]Jian-Ping, Lai,Saien, Lai,Florin, Tuluc,etc.Differences in the length of the carboxyl terminus mediate functional properties of neurokinin-1 receptor.[J].2008,105.
[56]Matsuda K,Piliponsky AM,Iikura M,etc.Monomeric IgE enhances human mast cell chemokine production: IL-4 augments and dexamethasone suppresses the response.[J].2005,116(6).
[57]Yosuke, Tanaka,Mitsunori, Hino,Akihiko, Gemma.Potential benefit of bosentan therapy in borderline or less severe pulmonary hypertension secondary to idiopathic pulmonary fibrosis-an interim analysis of results from a prospective, single-center, randomized, parallel-group study.[J].2017,17(1).
[58]David, Roblin,Gil, Yosipovitch,Brent, Boyce,etc.Topical TrkA Kinase Inhibitor CT327 is an Effective, Novel Therapy for the Treatment of Pruritus due to Psoriasis: Results from Experimental Studies, and Efficacy and Safety of CT327 in a Phase 2b Clinical Trial in Patients with Psoriasis.[J].2015,95.
[59]Mistry, Pragnesh,Laird, Michelle H. W.,Schwarz, Ryan S.,etc.Inhibition of TLR2 signaling by small molecule inhibitors targeting a pocket within the TLR2 TIR domain[J].2015,112(17).
[60]Yoshihiro Ogawa,Kazuwa Nakao,Hiroshi Arai,etc.Molecular cloning of a non-isopeptide-selective human endothelin receptor[J].1991,178(1).
[61]Kowalczyk, Agata,Kleniewska, Paulina,Kolodziejczyk, Michal,etc.The Role of Endothelin-1 and Endothelin Receptor Antagonists in Inflammatory Response and Sepsis[J].2015,63(Pt.1).
[62]Naoki Kajiwara,Tomomi Sasaki,Peter Bradding,etc.Activation of human mast cells through the platelet-activating factor receptor[J].2010,125(5).
[63]El-Agamy,D.S..Targeting c-kit in the therapy of mast cell disorders: Current update[J].2012,690(1).
[64]Aiji Sakamoto,Masashi Yanagisawa,Takeshi Sakurai,etc.Cloning and functional expression of human cDNA for the ETB endothelin receptor[J].1991,178(2).
[65]Lortholary, Olivier,Chandesris, Marie Olivia,Livideanu, Cristina Bulai,etc.Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study[J].2017,389(10069).
[66].Anti-IgE treatment with oral immunotherapy in multifood allergic participants: a double-blind, randomised, controlled trial[J].2018,3(2).
[67].Mast Cell Function: A New Vision of an Old Cell[J].2014,62(10).
[68]Hironori Matsushima,Nobuo Yamada,Hiroyuki Matsue,etc.The effects of endothelin-1 on degranulation, cytokine, and growth factor production by skin-derived mast cells[J].2004,34(7).
[69]Sulk,M.,Seeliger,S.,Aubert,J.,etc.Distribution and expression of non-neuronal transient receptor potential (TRPV) ion channels in rosacea[J].2012,132(4).
[70]Trent M. Woodruff,Anna J. Strachan,Nathan Dryburgh,etc.Antiarthritic activity of an orally active C5a receptor antagonist against antigen-induced monarticular arthritis in the rat[J].2002,46(9).
[71]Tkaczyk C,Gilfillan AM.Integrated signalling pathways for mast-cell activation.[J].2006,6(3).
[72]Sheen CH,Kulka M,Schleimer RP.Codeine induces human mast cell chemokine and cytokine production: involvement of G-protein activation.[J].2007,62(5).
[73]Woodruff TM,Shiels IA,Reid RC,etc.A potent human C5a receptor antagonist protects against disease pathology in a rat model of inflammatory bowel disease.[J].2003,171(10).
[74]Redegeld Frank A.,Kumari Sangeeta,Blank Ulrich,etc.Non-IgE mediated mast cell activation[J].2018,282(1).
[75]Ishiguro,N.,Hanabayashi,M.,Takahashi,N.,etc.Hyaluronan inhibits TLR-4 dependent cathepsin K and matrix metalloproteinase 1 expression in human fibroblasts[J].2013,430(2).
[76]Subramanian H,Gupta K,Guo Q,etc.Mas-related gene X2 (MrgX2) is a novel G protein-coupled receptor for the antimicrobial peptide LL-37 in human mast cells: resistance to receptor phosphorylation, desensitization, and internalization.[J].2011,286(52).
[77]Cahill, Katherine N.,Katz, Howard R.,Cui, Jing,etc.KIT Inhibition by Imatinib in Patients with Severe Refractory Asthma[J].2017,376(20).
[78]Ali, Hydar.Emerging Roles for MAS-Related G Protein-Coupled Receptor-X2 in Host Defense Peptide, Opioid, and NeuropeptideMediated Inflammatory Reactions[J].2017,136.
[79]Gauvreau, Gail M.,Arm, Jonathan P.,Boulet, Louis-Philippe,etc.Efficacy and safety of multiple doses of QGE031 (ligelizumab) versus omalizumab and placebo in inhibiting allergen- induced early asthmatic responses[J].2016,138(4).
[80]D. Regoli,F. Nantel.Pharmacology of neurokinin receptors[J].1991,31(6).
[81]Ilien B,Palanche T,Zoffmann S,etc.The neurokinin A receptor activates calcium and cAMP responses through distinct conformational states.[J].2001,276(37).
[82]Pejler, G.,Lundequist, A..Biological implications of preformed mast cell mediators[J].2011,68(6).
[83]Osler A. G..Studies on the Mechanism of Hypersensitivity Phenomena: III. The Participation of Complement in the Formation of Anaphylatoxin[J].1959.
[84]Atsushi Fukunaga,Steven Greenberg,Guenther Kaiser,etc.Efficacy and safety of omalizumab for the treatment of refractory chronic spontaneous urticaria in Japanese patients: Subgroup analysis of the phase 3 POLARIS study[J].2018,67(2).
[85]Lin TJ,McCurdy JD,Marshall JS.Toll-like receptor 4-mediated activation of murine mast cells.[J].2001,70(6).
[86]Schelfhout V,Louis R,Lenz W,etc.The triple neurokinin-receptor antagonist CS-003 inhibits neurokinin A-induced bronchoconstriction in patients with asthma.[J].2006,19(6).
[87]Maurer, Marcus,Wedemeyer, Jochen,Metz, Martin,etc.Mast cells promote homeostasis by limiting endothelin-1-induced toxicity.[J].2004,432(7016).
[88]Chung,L.,Ball,K.,Yaqub,A.,etc.Effect of the endothelin type A-selective endothelin receptor antagonist ambrisentan on digital ulcers in patients with systemic sclerosis: Results of a prospective pilot study[J].2014,71(2).
[89]Reber,L.L.,Frossard,N..Targeting mast cells in inflammatory diseases[J].2014,142(3).
[90]Mascarenhas, Nicholas L.,Wang, Zhenping,Chang, Yu-Ling,etc.TRPV4 Mediates Mast Cell Activation in Cathelicidin-Induced Rosacea Inflammation[J].2017,137(4).
[91]Rigoni, A.,Colombo, M.P.,Pucillo, C..Mast cells, basophils and eosinophils: From allergy to cancer.[J].2018,35.
[92]M L, Castellani,C, Ciampoli,M, Felaco,etc.Neuropeptide substance P induces mRNA expression and secretion of CXCL8 chemokine, and HDC in human umbilical cord blood mast cells.[J].2008,31(6).
[93]Bittner A,Gronen F,Brueck W,etc.Suppression of autoimmune encephalomyelitis by a neurokinin-1 receptor antagonist--a putative role for substance P in CNS inflammation.[J].2006,179(1).
[94]Ivana, Halova,Lubica, Draberova,Petr, Draber.Mast cell chemotaxis - chemoattractants and signaling pathways.[J].2012,3.
[95]A R, Johnson,T E, Hugli,H J, Müller-Eberhard.Release of histamine from rat mast cells by the complement peptides C3a and C5a.[J].1975,28.
[96]Iciar, Gárate,Borja, García-Bueno,José Luis Mu?oz, Madrigal,etc.Toll-like 4 receptor inhibitor TAK-242 decreases neuroinflammation in rat brain frontal cortex after stress.[J].2014,11.
[97]Ishizaka,K.,Saito,H.,Ishizaka,T..Mast Cells and IgE: From history to today[J].2013,62(1).
[98]Qin, Liu,Xinzhong, Dong.The role of the Mrgpr receptor family in itch.[J].2015,226.
[99]M, Yanagisawa,H, Kurihara,S, Kimura,etc.A novel potent vasoconstrictor peptide produced by vascular endothelial cells.[J].1988,332.
[100]Draber, Petr,Halova, Ivana,Polakovicova, Iva,etc.Signal transduction and chemotaxis in mast cells[J].2016,778.
[101]Busse W,Corren J,Lanier BQ,etc.Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma.[J].2001,108(2).
[102]TiphaineVoisin,AmélieBouvier,Isaac MChiu.Neuro-immune interactions in allergic diseases: novel targets for therapeutics[J].2017,29(6).
[103]Fowler-Taylor A,LaForce C,Fick R,etc.Effect of omalizumab on symptoms of seasonal allergic rhinitis: a randomized controlled trial.[J].2001,286(23).
[104]Masato Kubo.Mast cells and basophils in allergic inflammation[J].2018,54.
[105]Ehsan, Azimi,Vemuri B, Reddy,Kai-Ting C, Shade,etc.Dual action of neurokinin-1 antagonists on Mas-related GPCRs.[J].2016,(16).